Literature DB >> 19602754

Intravenous ondansetron causing severe bradycardia: two cases.

Nisha Afonso, Amit Dang, Viraj Namshikar, Sahish Kamat, Padmanabh V Rataboli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602754     DOI: 10.4103/0971-9784.53433

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


× No keyword cloud information.
  7 in total

1.  Prolonged drug-induced myoclonus: is it related to palonosetron?

Authors:  Sook Hui Chaw; Lucy Chan; Pui Kuan Lee; Jaseemuddeen A Bakar; Raveenthiran Rasiah; Li Lian Foo
Journal:  J Anesth       Date:  2016-08-10       Impact factor: 2.078

2.  Bradycardia After Intravenous Ondansetron with Asystole on Rechallenge: A Case Report.

Authors:  Jonathan H Rapp; Meggie Yuen; Teena Abraham
Journal:  Hosp Pharm       Date:  2015-11-19

3.  Does prophylactic ondansetron reduce norepinephrine consumption in patients undergoing cesarean section with spinal anesthesia?

Authors:  Feride Karacaer; Ebru Biricik; İlker Ünal; Selim Büyükkurt; Hakkı Ünlügenç
Journal:  J Anesth       Date:  2017-12-14       Impact factor: 2.078

4.  Ondansetron causing near fatal catastrophe in a renal transplant recipient.

Authors:  Sandeep Sahu; Sunaina Tejpal Karna; Anil Agarwal; Sushil Prakash Ambesh; Aneesh Srivastava
Journal:  Indian J Anaesth       Date:  2011-01

5.  Rate of administration of intravenous ondansetron.

Authors:  Smita Prakash; Meenu Aggarwal
Journal:  Indian J Anaesth       Date:  2011-07

6.  Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers.

Authors:  Joel Morganroth; Kristen K Flaharty; Simona Parisi; Cecilia Moresino
Journal:  Support Care Cancer       Date:  2015-06-26       Impact factor: 3.603

7.  Intraoperative pulseless ventricular tachycardia after Ondansetron.

Authors:  Sukhen Samanta; Kajal Jain; Sujay Samanta; Tanmoy Ghatak
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.